Hickory Point Bank & Trust’s Pfizer PFE Stock Holding History

Hickory Point Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$337K	Hold	13,995	–	–	0.2%	98
2026 Q1	$393K	Sell	13,995 -353	-2%	-$9.4K	0.26%	85
2025 Q4	$357K	Sell	14,348 -711	-5%	-$17.9K	0.26%	85
2025 Q3	$384K	Sell	15,059 -428	-3%	-$10.6K	0.29%	82
2025 Q2	$375K	Sell	15,487 -997	-6%	-$23.3K	0.3%	78
2025 Q1	$418K	Sell	16,484 -802	-5%	-$21K	0.37%	64
2024 Q4	$459K	Buy	+17,286	New	+$469K	0.41%	54

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Hickory Point Bank & Trust's PFE Position: Q2 2026 in Review

Hickory Point Bank & Trust held its Pfizer (PFE) position steady in Q2 2026 at 13,995 shares worth $337K. The position accounts for 0.2% of the portfolio, ranked #98.

Hickory Point Bank & Trust first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $459K in Q4 2024. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Hickory Point Bank & Trust held 13,995 shares of Pfizer worth $337K as of Q2 2026.
Hickory Point Bank & Trust left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.2% of Hickory Point Bank & Trust's portfolio in Q2 2026, its #98 holding.
Hickory Point Bank & Trust first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Hickory Point Bank & Trust's Pfizer position peaked at $459K in Q4 2024.
1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hickory Point Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.